Skip to main content
OpenTrials
Completed

NCT Number: NCT04745923

Physical Activity Level in Patients with Chronic Kidney Disease During COVID-19 Pandemic

In the literature, there are no studies evaluating fear of COVID-19, anxiety, depression, physical activity, fear of movement and quality of life in patients with chronic kidney disease during COVID-19 pandemic. The investigators will evaluate these parameters in patients with chronic kidney disease and compare the findings of healthy individuals during COVID-19 pandemic

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 Anxiety Disorders Behavior Behavioral Symptoms COVID-19 Chronic Disease Chronic Kidney Diseases Coronaviridae Infections Coronavirus Infections Depression Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Infections Kidney Diseases Lung Diseases Male Urogenital Diseases Mental Disorders Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Renal Insufficiency Renal Insufficiency, Chronic Respiratory Tract Diseases Respiratory Tract Infections Urogenital Diseases Urologic Diseases Virus Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hacettepe University, Faculty of Physical Therapy and Rehabilitation

Ankara, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having been diagnosed with chronic kidney disease
  • Being clinically stable
  • Volunteering to participate in the research

Exclusion criteria

  • Having a cognitive problem
  • Not being literate

Treatment and study plan

Primary outcomes

  1. Fear of COVID-19

    Time frame: 5 minutes

    COVID-19 phobia will be evaluated using Fear of COVID-19 Scale.

  2. Physical activity

    Time frame: 5 minutes

    Physical activity level will be evaluated using International Physical Activity Questionnaire - Short Form (IPAQ-SF).

Secondary outcomes

  1. Qol

    Time frame: 10 minutes

    Quality of life will be evaluated using SF-36

  2. Anxiety and depression

    Time frame: 5 minutes

    Anxiety and depression will be evaluated using Hospital Anxiety and Depression scale (HADS).

  3. Fear of movement

    Time frame: 10 minutes

    Fear of movement will be evaluated using the Tampa Scale for Kinesiophobia

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Official study title

Fear of COVID-19 and Physical Activity Level in Patients with Chronic Kidney Disease During COVID-19 Pandemic

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Feb 9, 2021
Registry last updated
Nov 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.